Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of
a daily single oral dose of tasimelteon and matching placebo in male and female participants
with DSWPD.